Locum pharmacist warned over ‘dismissive’ handling of EHC request
In Profession news
Follow this topic
Bookmark
Record learning outcomes
A Manchester locum pharmacist has received a formal regulatory warning over his handling of a request for emergency hormonal contraception (EHC).
Ahmad Abdelnabi received a warning from the General Pharmaceutical Council on January 8 after the regulator’s investigations committee considered the details of the incident, which took place on September 13, 2024.
When a patient attended Cameolord Pharmacy in Manchester city centre requesting EHC, Mr Abdelnabi was reportedly “short and dismissive” with her according to the committee.
Mr Abdelnabi failed to make any notes of the consultation and his reasoning for not supplying EHC.
Nor did he signpost the patient to an alternative provider or discuss care options with her.
“The patient later discovered they were in fact pregnant and suffered a miscarriage,” the committee noted.
Mr Abdelnabi was found to have breached five professional standards, including those relating to person-centred care, using professional judgement and behaving in a professional manner.
The investigations committee commented: “Mr Abdelnabi is warned that effective, compassionate, person-centred communication is key to providing effective pharmacy provision and that consultation decisions should be fully explained to patients and recorded, including signposting to alternative support where appropriate.”
The warning will appear on his registry entry until January 8, 2027.
His case follows two recent warnings related to EHC provision.
In September 2025, a Surrey pharmacist was told that when she refused to make a morning after pill supply on religious grounds while on the shop floor she had failed to fully consider the patient’s privacy needs into account, demonstrating “poor judgement”. The pharmacist did, however, signpost the patient to a nearby pharmacy.
And in December last year a pharmacist was warned after she mistakenly dispensed buprenorphine to a patient instead of a prescribed EllaOne tablet, causing the patient to experience dizziness and nausea and require medical attention.